Hofseth BioCare ASA: Terms of the Subsequent Offering

Core Points - The company Hofseth Biocare ASA (HBC) is proceeding with a Subsequent Offering of up to 16,666,666 new Ordinary Shares, aiming to raise approximately NOK 30 million [2][3] - Eligible shareholders will receive non-transferable subscription rights, allowing them to subscribe for one Offer Share for each 0.1134 existing share held as of the Record Date [4] - The subscription period for the Subsequent Offering is set from 10 November 2025 to 20 November 2025 [5] Offering Details - The Subsequent Offering is conditional upon necessary corporate resolutions being passed, including an extraordinary general meeting on 20 November 2025 [7] - The due date for payment for the Offer Shares is expected to be on 26 November 2025, with shares becoming listed on Euronext Oslo Børs around 2 December 2025 [6] - Over-subscription is permitted, and any remaining Offer Shares may be allocated to strategic investors at the Board's discretion [3][5] Legal and Regulatory Information - A national prospectus will be published in accordance with the Norwegian Securities Trading Act, and it will be available on the company's website prior to the subscription period [6] - The announcement is not an offer to sell or a solicitation to purchase any securities and is subject to specific legal restrictions in certain jurisdictions [10][15]